| Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy (NCT05353738) | University Hospital, Bordeaux | 2021-09-01 |
| Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV (NCT05085145) | Beijing 302 Hospital | 2021-09-01 |
| Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death (NCT04914832) | Shabir Madhi | 2021-08-30 |
| A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults (NCT05037097) | Arcturus Therapeutics, Inc. | 2021-08-30 |
| Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer (NCT05018078) | Beijing 302 Hospital | 2021-08-30 |
| Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery (NCT06636760) | Indonesia University | 2021-08-27 |
| Factors Associated With Decisions to Withhold or Withdraw Intensive Care (NCT05394961) | Uppsala University | 2021-08-26 |
| Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults (NCT04952727) | Jiangsu Province Centers for Disease Control and Prevention | 2021-08-26 |
| Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis (NCT05520944) | Dr. Ferrer BioPharma | 2021-08-26 |
| Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior (NCT05043623) | Murdoch Childrens Research Institute | 2021-08-26 |
| Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). (NCT05011513) | Pfizer | 2021-08-25 |
| Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants (NCT05004181) | BioNTech SE | 2021-08-25 |
| COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States (NCT05020145) | Pfizer | 2021-08-25 |
| Effects of Inspiratory Muscle Training After Covid-19 (ReCOV) (NCT05024474) | Karolinska Institutet | 2021-08-24 |
| Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran (NCT05097664) | Isfahan University of Medical Sciences | 2021-08-23 |
| Cognitive and Psychological Disorders After Severe COVID-19 Infection (NCT04937582) | Central Hospital, Nancy, France | 2021-08-23 |
| SARS-CoV-2 Infection in COVID-19 Vaccinated Patients (NCT05060939) | Hospices Civils de Lyon | 2021-08-20 |
| Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease (NCT04998214) | Assiut University | 2021-08-19 |
| Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination (NCT04794829) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-19 |
| Electrical Stimulation for Critically Ill Post-Covid-19 Patients (NCT05198466) | Baylor College of Medicine | 2021-08-18 |
| A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia (NCT04659122) | Airway Therapeutics, Inc. | 2021-08-17 |
| Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic (NCT04974164) | Sinovac Research and Development Co., Ltd. | 2021-08-17 |
| Impact of Vaccination in Acute COVID-19 (NCT05198453) | University Medical Centre Ljubljana | 2021-08-16 |
| Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid Patients (NCT05311852) | Department of Neurorehabilitation, Hospital of Vipiteno-Sterzing (BZ) Italy | 2021-08-16 |
| Oral Curcumin, Quercetin and Vitamin D3 Supplements for Mild to Moderate Symptoms of COVID-19 (NCT04603690) | Liaquat University of Medical & Health Sciences | 2021-08-16 |
| International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE) (NCT05096091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-16 |
| Rehabilitation in Severely Ill Inpatients With COVID-19 (NCT05104411) | Seoul National University Bundang Hospital | 2021-08-14 |
| COVID-19 Serologic Strategies for Skilled Nursing Facilities (NCT05270980) | NYU Langone Health | 2021-08-11 |
| NDV-HXP-S Vaccine Clinical Trial (COVIVAC) (NCT05940194) | Institute of Vaccines and Medical Biologicals, Vietnam | 2021-08-11 |
| Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19 (NCT05185284) | Promomed, LLC | 2021-08-11 |
| Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China (NCT04954131) | Zhejiang Clover Biopharmaceuticals, Inc. | 2021-08-10 |
| Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19) (NCT05037188) | Biocad | 2021-08-10 |
| Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations (NCT04944095) | Dr. Sidney J. Stohs | 2021-08-10 |
| Neuromodulation in COVID-19 Patients (NCT04808284) | D'Or Institute for Research and Education | 2021-08-10 |
| Long-term Impact on Cardiopulmonary Function and Quality of Life in Patients Recovered From COVID-19. (NCT05386485) | Universidad Peruana Cayetano Heredia | 2021-08-07 |
| A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine (NCT04967742) | United Biomedical Inc., Asia | 2021-08-05 |
| A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients (NCT04869228) | Suzhou Kintor Pharmaceutical Inc, | 2021-08-04 |
| ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19 (NCT04988035) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-03 |
| Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities (NCT05449418) | Kaiser Permanente | 2021-08-01 |
| Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19) (NCT05003479) | Shenzhen Kangtai Biological Products Co., LTD | 2021-08-01 |
| Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults (NCT04950751) | Clover Biopharmaceuticals AUS Pty | 2021-08-01 |
| ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases (NCT05467917) | Columbia University | 2021-08-01 |
| Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure (NCT04550338) | University of Alabama at Birmingham | 2021-08-01 |
| Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines (NCT05095298) | Huashan Hospital | 2021-08-01 |
| Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab Application (NCT06233357) | University of Ulm | 2021-08-01 |
| Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 (NCT04990544) | Shanghai Zerun Biotechnology Co.,Ltd | 2021-07-31 |
| Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19) (NCT04498325) | Washington University School of Medicine | 2021-07-31 |
| Clinical Trial of SARS-CoV-2 mRNA Vaccine in China (NCT05364047) | AIM Vaccine Co., Ltd. | 2021-07-31 |
| PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS (NCT05279365) | DHR Health Institute for Research and Development | 2021-07-30 |
| COVID-19 Vaccine Biomarker Study in Multiple Sclerosis (NCT05121662) | Columbia University | 2021-07-29 |
| Safety and Efficacy of KOVIR in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) (NCT05042141) | Sao Thai Duong Joint Stock Company | 2021-07-28 |
| Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years (NCT05112913) | Sinovac Research and Development Co., Ltd. | 2021-07-27 |
| Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19 (NCT05650905) | Medical University of Vienna | 2021-07-26 |
| A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects (NCT04949490) | BioNTech SE | 2021-07-26 |
| Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 (NCT04805671) | Invivyd, Inc. | 2021-07-26 |
| Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents (NCT04992208) | Sinovac Life Sciences Co., Ltd. | 2021-07-24 |
| A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures (NCT04832919) | New York University | 2021-07-23 |
| A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above (NCT04847102) | Walvax Biotechnology Co., Ltd. | 2021-07-22 |
| Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial (NCT05930002) | Ain Shams University | 2021-07-21 |
| Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults (NCT04672291) | Oncovir, Inc. | 2021-07-21 |
| Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses. (NCT05157178) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2021-07-20 |
| EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 (NCT04960202) | Pfizer | 2021-07-16 |
| The Effect of Home-based Rehabilitation Program After COVID-19 Infection (NCT05317975) | National Taiwan University Hospital | 2021-07-15 |
| Non-invasive Nervus Vagus Stimulation in Patients With COVID-19 and ARDS (NCT05058742) | Vienna Hospital Association | 2021-07-15 |
| COVID-19 Immunity Assessment (NCT05080231) | DxTerity Diagnostics | 2021-07-15 |
| Novel Experimental COVID-19 Therapies Affecting Host Response (NCT04924660) | Sean Collins | 2021-07-15 |
| Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19 (NCT04928495) | Universidade Federal do Ceara | 2021-07-15 |
| Integrative Treatment Methods in COVID-19 (NCT05089578) | Amasya University | 2021-07-15 |
| Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection (NCT05196477) | R-Pharm | 2021-07-14 |
| Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults (NCT04475991) | Hospital General de México Dr. Eduardo Liceaga | 2021-07-13 |
| Booster Vaccination Against COVID-19 (NCT04979949) | Health Institutes of Turkey | 2021-07-12 |
| Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 (NCT04982068) | Shanghai Zerun Biotechnology Co.,Ltd | 2021-07-12 |
| A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients (NCT05384314) | Beaumont Hospital | 2021-07-12 |
| Immunogenicity and Safety of an Inactivated COVID-19 Vaccine (NCT04953325) | Sinovac Research and Development Co., Ltd. | 2021-07-09 |
| Study of Efficacy of Different Treatment Regimens of Olokizumab (NCT05187793) | R-Pharm | 2021-07-08 |
| B Cell Responses in COVID-19 (NCT06891170) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2021-07-07 |
| Retrospective Evaluation of Lung Pathology in Subjects With COVID-19 (NCT04878913) | Vicore Pharma AB | 2021-07-07 |
| The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey (NCT05312619) | Dr. Daniel Cameron & Associates | 2021-07-07 |
| Multisite Observational Maternal and Infant Study for COVID-19 (NCT05031468) | Emory University | 2021-07-06 |
| Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic (NCT06334731) | Methodist Health System | 2021-07-06 |
| Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients (NCT04743401) | VA Office of Research and Development | 2021-07-05 |
| Efficacy and Safety of ES16001 in Patients With COVID-19 (NCT05525182) | Genencell Co. Ltd. | 2021-07-05 |
| Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen (NCT04839965) | Ampio Pharmaceuticals. Inc. | 2021-07-05 |
| Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above (NCT04917523) | China National Biotec Group Company Limited | 2021-07-02 |
| Cognitive Assessment in COVID-19 Positive Patients Using the DANA App (NCT05143333) | Johns Hopkins University | 2021-07-01 |
| The Relationship Between Covid-19 and Pneumothorax in Patients Hospitalized With Covid-19 During the Pandemic (NCT05677776) | Erol Olcok Corum Training and Research Hospital | 2021-07-01 |
| Safety and Efficacy of Softgel KOVIR (TD0068) in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) (NCT05082727) | Sao Thai Duong Joint Stock Company | 2021-07-01 |
| Probiotic and Colchicine in COVID-19 (NCT05911022) | Ain Shams University | 2021-07-01 |
| Safety and Efficacy of Ruxolitinib for COVID-19 (NCT04348071) | University of Colorado, Denver | 2021-07-01 |
| Prevalence and Impact of COVID-19 on Maternal and Infant Health in African Populations (NCT05303168) | Barcelona Institute for Global Health | 2021-07-01 |
| Long COVID Kids DK - Investigating Long-term Covid-19 (NCT04786353) | Rigshospitalet, Denmark | 2021-07-01 |
| Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors (NCT05164744) | Weill Medical College of Cornell University | 2021-07-01 |
| Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2 (NCT04375046) | Kafrelsheikh University | 2021-07-01 |
| SARS-CoV-2/COVID-19 Infection Among Health Care Workers (NCT04826718) | Universidade de Cabo Verde | 2021-07-01 |
| CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2 (NCT05467930) | Columbia University | 2021-07-01 |
| To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. (NCT04955626) | BioNTech SE | 2021-07-01 |
| Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc) (NCT05084950) | Centre Scientifique de Monaco | 2021-07-01 |
| An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older (NCT05765773) | Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 2021-07-01 |
| Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients (NCT05765617) | Universitas Sebelas Maret | 2021-07-01 |
| Oropharyngeal Immunoprophylaxis With High Polyphenolic Olive Oil as Clinical Spectrum Mitigating Factor in COVID-19. (NCT05685901) | Hospital General Nuestra Señora del Prado | 2021-07-01 |